Angiogenesis suppression was evaluated in a breast cancer study through BM-MSCs-exo carrying miR221-3p, miR-16, miR-100, and miR-23b, leading to the downregulation of VEGF. This evidence concerns the gene VEGFA and breast carcinoma.